what is the agile study? research for aml patients with the idh1 mutation
Published 1 year ago • 18 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
4:43
what are the latest acute myeloid leukemia therapies?
-
30:35
treatment approaches in aml: key testing for personalized care
-
33:20
aml treatment decisions: what’s right for you?
-
2:39
how do gene mutations affect aml treatment choices?
-
3:55
how is acute myeloid leukemia (aml) treated?
-
4:36
expert advice for aml patients when making treatment choices
-
4:00
diagnosing and treating aml: what testing is essential?
-
3:50
key aml testing for better care: understanding prognosis and treatment choices
-
2:26
what are the latest updates on the idh1 and idh2 inhibitor studies?
-
6:35
idh1/2 inhibitors in aml
-
1:47
what does transfusion burden mean in acute myeloid leukemia?
-
2:11
assessing untreated aml patients who are ineligible for intensive chemotherapy
-
2:15
what is the impact of cytogenetics on aml care?
-
6:53
ivosidenib for advanced idh1-mutated cca
-
7:46
updates in aml treatment and research from asco 2023
-
4:56
clinical response in patients with idh1 mutation-positive hematologic malignancies
-
4:49
expert advice | shining a light on equitable aml care
-
7:06
case 3: idh2-mutated aml
-
3:49
clinical challenges with new and emerging idh1/idh2 inhibito